Gastrooesophageal cancer+1
Not recruitingStudy on 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Stomach and Gastroesophageal Junction Cancer in Patients Undergoing Chemotherapy
Study on 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Stomach and Gastroesophageal Junction Cancer in Patients Undergoing Chemotherapy
- Disease:Gastrooesophageal cancerGastric cancer
- Substances:68Ga-FAPI-46Fludeoxyglucose (18F)
Denmark- Participants:18–64 years · 65+ years
- Substances:68Ga-FAPI-46
- Sponsor:Aalborg University Hospital













